DOCRO definition
Examples of DOCRO in a sentence
DOCRO shall provide to LEXON a written report summarizing DOCRO's findings and activities upon DOCRO's completion of the technology assessment portion of this Agreement and upon termination of this Agreement.
LEXON must provide written notification to DOCRO within forty-eight (48) hours of the issuance of the report if LEXON desires DOCRO not to perform the work that DOCRO recommends in the report.
If timely payment for invoiced fees is not made, in addition to other remedies, DOCRO may impose and LEXON shall pay, a late payment charge equal to one and one-half percent (1.5%) of the overdue amount each month.
Further, if a telomerase antigen is determined by DOCRO to be overexpressed in malignant disease and not in non-malignant disease or apparently healthy normals and LEXON agrees, DOCRO shall develop an enzyme immunoassay for such telomerase antigen to confirm the results in the blood or other fluid specimen matrix of a statistically significant number (maximum of 400) patients.
DOCRO shall provide to LEXON an analysis and written report of the work performed with recommendations for the next steps to be taken by DOCRO conducted in Section 1.1. and Section 1.2. on a bi-weekly basis from the inception of the project.
DOCRO is engaged in providing technology assessment, technology development, and laboratory and clinical trial services to medical device developers, in particular, providing technology assessment and technology development services related to the development and commercialization of in vitro diagnostic assays for determining the amount of tumor markers or other analytes in the tissues, blood, other fluids, and other specimen matrices of mammals.
In consideration of the mutual promises specified below, DOCRO offers to provide technology assessment and technology development professional services to LEXON in accordance with the terms and conditions of this Agreement, which LEXON accepts.
DOCRO shall provide to LEXON on a bi-weekly basis written reports of DOCRO's progress and recommendations for the next segment of work to be performed.
The basis for these amounts and the dates for additional payments to be made by LEXON to DOCRO are set forth in Attachment A.
Further, if an ebaf protein is determined by DOCRO to be overexpressed in malignant disease and not in non-malignant disease or apparently healthy normals and LEXON agrees, DOCRO shall develop an enzyme immunoassay for such ebaf protein to confirm the results in the blood or other fluid specimen matrix of a statistically significant number (maximum of 400) patients.